within Pharmacolibrary.Drugs.ATC.C;

model C07FB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 10 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,
    adminCount     = 1,
    Vd             = 0.2,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Metoprolol and felodipine is a fixed-dose combination of a beta-1 selective adrenergic blocker (metoprolol) and a calcium channel blocker of the dihydropyridine class (felodipine). This combination is used primarily for the treatment of hypertension and sometimes for angina pectoris. Both drugs are widely approved and used today for cardiovascular conditions.</p><h4>Pharmacokinetics</h4><p>No published literature was found that reports pharmacokinetic models or parameters explicitly for the fixed-dose combination product or its specific pharmacokinetic interaction in humans. The following are best estimates based on typical pharmacokinetic parameters of orally administered metoprolol tartrate and felodipine in healthy adults.</p><h4>References</h4><ol><li><p>Larsson, R, et al., &amp; Regårdh, CG (1990). Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function. <i>Journal of clinical pharmacology</i> 30(11) 1020–1030. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1990.tb03589.x&quot;>10.1002/j.1552-4604.1990.tb03589.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2243149/&quot;>https://pubmed.ncbi.nlm.nih.gov/2243149</a></p></li><li><p>Wang, WG, et al., &amp; Liu, ZY (2007). [Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits]. <i>Yao xue xue bao = Acta pharmaceutica Sinica</i> 42(11) 1206–1214. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18300480/&quot;>https://pubmed.ncbi.nlm.nih.gov/18300480</a></p></li><li><p>Prisant, LM, et al., &amp; Carr, AA (1992). Novel drug-delivery systems for hypertension. <i>The American journal of medicine</i> 93(2A) 45S–55S. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(92)90294-l&quot;>10.1016/0002-9343(92)90294-l</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1519636/&quot;>https://pubmed.ncbi.nlm.nih.gov/1519636</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07FB02;
